MoneyWorks4Me

DIL informs about financial results

14 Aug 2018 Evaluate

DIL has informed that the board of Directors of the Company at its meeting held on August 14, 2018, has approved the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2018 as per Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; to consider and submit consolidated financial results effective from quarter ended June 30, 2018, for the financial year 2018-19.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..